Abstract
Programmed cell death (apoptosis) plays a role in the pathophysiology of many diseases and in the outcome of treatment. Apoptosis is the likely mechanism behind the cytoreductive effects of standard chemotherapeutic and radiation treatments, rejection of organ transplants, cellular damage in collagen vascular disorders, and delayed cell death due to hypoxic-ischemic injury in myocardial infarction and neonatal hypoxic ischemic injury. Observations about the role of apoptosis have fueled the development of novel agents and treatment strategies specifically aimed at inducing or inhibiting apoptosis.
Despite these research developments there are no clinical entities where specific measures of apoptosis are used in either diagnosis or patient management. Part of the difficulty in bridging the gap between the basic science understanding of apoptosis and the clinical application of this information is the lack of a sensitive marker to monitor programmed cell death in association with disease progression or regression. Technetium-99m labeled annexin V localizes at sites of apoptosis in-vivo, due to its nanomolar affinity for membrane bound phosphatidylserine. Radiolabeled annexin V imaging permits identification of the site and extent of apoptosis in experimental animals. Annexin V has been successfully used in animal models to image organ transplant rejection, characterize successful therapy of tumors, pinpoint acute myocardial infarction, and identify hypoxic ischemic brain injury of the newborn and adult. Early studies in human subjects suggest that 99mTc annexin imaging will be also be useful to identify rejection in transplant recipients, localize acute myocardial infarction, and characterize the effectiveness of a single treatment in patients with tumors.
This review describes the imaging approaches to detect and monitor apoptosis in-vivo that are presently in early clinical trials. The preliminary data are extrapolated to identify conditions where apoptosis imaging may be valuable in clinical decision making. These conditions include: transplant rejection; hypoxic/ischemic injury of heart and brain; and determining the efficacy of therapy in cancer, heart failure and osteoporosis.
Similar content being viewed by others
References
Ramachandran A, Madesh M, Balasubramanian KA. Apoptosis in the intestinal epithelium: Its relevance in normal and pathophysiological conditions. J Gastroenterol Hepatol 2000; 15: 109–120.
Dahmoun M, Boman K, Cajander S, Westin P, Backstrom T. Apoptosis, proliferation, and sex hormone receptors in super-ficial parts of human endometrium at the end of the secretory phase. J Clin Endocrinol Metab 1999; 84: 1737–1743.
Ju ST, Matsui K, Ozdemirli M. Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction. Int Rev Immunol 1999; 18: 485–513.
Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456–1462.
The London Economist. Science and Technology; Honorable death. May 4th 1996: pp. 83–84.
Rimon G, Bazenet CE, Philpott KL, et al. Increased surface phosphatidylserine is an early marker of neuronal apoptosis. J Neurosci Res 1997; 48: 563–570.
Krams SM, Martinez OM. Apoptosis as a mechanism of tissue injury in liver allograft rejection. Seminars in Liver Disease 1998; 18: 153–167.
Olivetti G, Abbi R, Quani F, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131–1141.
Darzykiewicz Z. Apoptosis in antitumor strategies: Modulation of cell cycle or differentiation. J Cell Biol 1995; 58: 151–159.
Stefanec T. Endothelial apoptosis; Could it have a role in the pathogenesis and treatment of disease? Chest 2000; 117: 841–854.
Rupnow BA, Knox SJ. The role of radiation-induced apoptosis as a determinate of tumor responses to radiation therapy. Apoptosis 1999; 4: 115–143.
Brooks PC, Montgomery AMP, Rosenfeld M, et al. Integrin γ v γ 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blodd vessels. Cell 1994; 79: 1157–1164.
Rouslahti E, Engvall E. Perspective Series: Cell Adhesion in Vascular Biology. J Clin Invest 1997; 100(Suppl): S53-S56.
Polverino AJ, Patterson SD. Selective activation of caspases during apoptotic induction in HL-60 cells. Effects of a tetrapeptide inhibitor. J Biol Chem 1997; 272: 7013–7021.
Hara H, Friedlander RM, Gagliardini V, et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Porc Natl Acad Sci USA 1997; 94: 2007–2012.
Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat mode of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998; 101: 1992–1999.
Cursio R, Gugenheim J, Ricci JE, et al. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 1999; 13: 253–261.
Holly TA, Drincic A, Byaun Y, et al. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 1999; 31: 1709–1715.
Farber A, Connors JP, Friedlander RM, Wagner RJ, Powell RJ, Cronenwett JL. A specific inhibitor of apoptosis decreases tissue injury after intestinal ischemia-reperfusion in mice. J Vasc Surg 1999; 30: 752–760.
Ushmorov A, Ratter F, Lehmann V, Droge W, Schirrmacher V, Umansky V. Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release. Blood 1999; 93: 2342–2352.
Tamm I, Wang Y, Sausville E, et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Baqx, caspases, and anticancer drugs. Cancer Res 1998; 58: 5315–5320.
Blankenberg FG, Strauss HW. Strategies to image cardiovascular apoptosis. Cardiology Clinics 2001.
Star-Lack JM, Adalsteinsson E, Adam MF, et al. In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparision with oxygen tension measurements. Am J Neuroradiol 2000; 21: 183–193.
Bhakoo KK, Bell JD. The application of NMR spectroscopy to the study of apoptosis. Cell Mol Biol 1997; 43: 621–629.
Hakumaki JM, Poptani H, Sandmair AM, Yla-Herttuala S, Kauppinen RA. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosis. Nature Medicine 1999; 5: 1323–1327.
Blankenberg FG, Katsikis PD, Storrs RW, et al. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 1997; 89: 3778–3786.
Mehmet H, Yue X, Penrice J, et al. Relation of impaired energy metabolism to apoptosis and necrosis following transient cerebral hypoxia-ischaemia. Cell Death Differ 1998; 5: 321–329.
Jung WI, Sieverding L, Breuer J, et al. Circulation 1998; 97: 2536–2542.
Negendank W, Sauter R. Intratumoral lipids in 1H MRS in vivo in brain tumors: Experience of the Siemens Cooperative Clinical Trial. Anticancer Research 1996; 16: 1533–1538.
Blankenberg FG, Katsikis PF, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998; 95: 6349–6354.
Blankenberg FG, Katsikis PD, Tait JF, et al. Imaging of apoptosis (programmed cell dealth) with technetium 99m annexin V. Journal of Nuclear Medicine 1999; 40: 184–191.
Ohtsuki K, Akashi K, Aoka Y, et al. 99mTc-HYNIC Annexin V:ARadiopharmaceutical for the in vivo detection of apoptosis. European Journal of Nuclear Medicine 1999; 26: 1251–1258.
Stratton JR, Dewhurst TA, Kasina S, et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation 1995; 92: 3113–3121.
Tait JF, Cerqueira MD, Dewhurst TA. Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thrombosis Res 1994; 75: 491–501.
Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, vanOers MHJ. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84: 1415–1420.
Boersma AMW, Nooter K, Oostrum RG, Stoter G. Quantification of apoptotic cells with fluorescein isothiocyante labeled annexin V in Chinese hamster overay cell cultures treated with cisplatic. Cytometry 1996; 24: 123–130.
van Heerde WL, de Groot PG, Reutelingsperger CPM. The complexity of the phospholipid binding protein annexin V. Thromb and Hemostasis 1995; 73: 172–179.
Romisch J, Schuler E, Bastian B, et al. Annexins I to VI: Quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul Fibrinolysis 1992; 3: 11–17.
Kaneko N, Matsuda R, Hosoda S, Kajita T, Ohta Y. Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin Chim Acta 1996; 251: 65–80.
Reutelinsperger CP, can Heerde W, Hauptmann R, et al. Differential tissue expression of Annexin VIII in Human. FEBS Lett 1994; 349: 120–124.
Blankenberg F, Ohtsuki K, Strauss HW. Dying a thousand deaths. Radionuclide imaging of apoptosis. Q J Nucl Med 1999; 43: 170–176.
Vriens PW, Blankenberg FG, Stoot JH, et al. The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg 1998; 116: 844–853.
Blankenberg FG, Robbins RC, Stoot JH, et al. Radionuclide imaging of acute lung transplant rejection with annexin V. Chest 2000; 117: 834–840.
Ogura Y, Krams SM, Martinez OM, et al. Radiolabeled annexin V imaging: diagnosis of allograft rejection in an experimental rodent model of liver transplantation. Radiology 2000; 214: 795–800.
D'Arceuil HE, Blankenberg FG, De Crespigny AJ, Moseley ME, Strauss HW, Rhine WD. Radionuclide scanning combined with MR diffusion weighted imaging investigation of apoptosis in neonatal rabbit HIE. Pediatric Research 1998; 43: 317A.
Blankenberg FG, Busch E, Yenari MA, et al. In vivo imaging of apoptotic cell death associated with cerebral hemispheric ischemia using 99mTc radiolabeled annexin V. (Abstract) Stroke 1998; 29: 330.
Lee JD, Kim DI, Ryu YH, Whang GJ, Park CI, Kim DG. Technetium-99m-ECD brain SPECT in cerebral palsy: Comparision with MRI. J Nucl Med 1998; 39: 619–623.
Rutherford MA, Pennock JM, Counsell SJ, et al. Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with Hypoxic-Ischemic encephalopathy. Pediatrics 1998; 102: 323–328.
Oka A, Belliveau MJ, Rosenberg PA, et al. Vunerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention. J Neurosci 1993; 13: 1441–1453.
Allan WC, Riviello JJ. Perinatal cerebrovascular disease in the neonate: Parenchymal ischemic lesions in term and preterm infants. Pediatric Clin North Am 1992; 39: 621–650.
Barkovich JA, Westmark K, Partridge C, Sola A, Ferriero DM. Perinatal asphyxia: MR findings in the first 10 days. Am J of Neuroradiol 1995; 16: 427–438.
Pulera MR, Adams LM, Liu H, et al. Apoptosis in a neonatal rat model of cerebral Hypoxia-Ischemia. Stroke 1998; 29: 2622–2630.
Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic injury. J Clin Invest 1998; 101: 1992–1999.
Hara H, Friedlander RM, Gagliardini V, et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 2007–2012.
Vexler ZS, Roberts TPL, Bollen AW, Derugin N, Arieff AI. Transient cerebral ischemia. Association of apoptosis induction with hypoperfusion. J Clin Invest 1997; 99: 1453–1459.
Du C, Hu R, Csernansky CA, Hsu CY, Choi DW. Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis? J Cerebr Blood Flow Metab 1996; 16: 195–201.
Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. The New England Journal of Medicine 1996; 335: 1182–1195.
Yaoita H, Ogawa K, Maehara K, et al. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor [see comments]. Circulation 1998; 97: 276–281.
Hasegawa S, Nishimura T. Personal commnication.
Geng Y-J, Holm J, Hygren S, et al. Expression of the macrophage scavenger receptor in atheroma. Arterioscler Thromb Vasc Biol. 1995; 15: 1995–2002.
Blankenberg FG, Strauss HW. Non-invasive diagnosis of acute heart-or lung-transplant rejection using radiolabeled annexin V. Pediatric Radiology 1999; 29: 299–305.
Weis M, von Scheidt W. Cardiac allograft vasculopathy: A review. Circulation 1997; 96: 2069–2077.
Dong C, Wilson JE, Winters GL, McManus BM. Human transplant coronary artery disease: Pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest 1996; 74: 921–931.
Lamb JR, Friend SH. Which quesstimate is the best quesstimate? Predicting chemotherapeutic outcomes. Nature Medicine 1997; 9: 962–963.
Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997; 3: 1457–1466.
Blankenberg FG, Tait JF, Strauss HW. Apoptotic cell death: Its implications for imaging in the next millenium. Eur J Nucl Med 2000; 27: 359–367.
Martin DS, Schwartz GK. Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascade. Oncology Research 1997; 9: 1–5.
Zhang J, Dawson VL, Dawson TM, et al. Nitric Oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994; 263: 687–689.
Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nature Medicine 1996; 2: 1132–1136.
Koletzko B, Aggett PJ, Bindels JG, et al. Growth, development and differentiation: A functional food science approach. Br J Nutr 1998; 80: S5-S45.
Manolagas SC. Cellular and molecular mechanisms of osteoporosis. Aging (Milano) 1998; 10: 182–190.
Reszka AA, Halasy-Nagy JM, Masarachia PJ, Rodan GA. Bis-phosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase. J Biol Chem 1999; 274: 34967–34973.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blankenberg, F.G., Strauss, H.W. Will imaging of apoptosis play a role in clinical care? A tale of mice and men. Apoptosis 6, 117–123 (2001). https://doi.org/10.1023/A:1009640614910
Issue Date:
DOI: https://doi.org/10.1023/A:1009640614910